Portal de Periódicos da CAPES

Ibogaine in Acute Opioid Withdrawal: An Open Label Case Series

2000; Wiley; Volume: 909; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.2000.tb06687.x

1749-6632

Kenneth Alper, Howard S. Lotsof, Geerte M. N. Frenken, D Luciano, Jan Bastiaans,

Pharmacological Receptor Mechanisms and Effects

Annals of the New York Academy of SciencesVolume 909, Issue 1 p. 257-259 Ibogaine in Acute Opioid Withdrawal: An Open Label Case Series KENNETH R. ALPER, Corresponding Author KENNETH R. ALPER Brain Research Laboratories, Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA Comprehensive Epilepsy Center, Department of Neurology, New York University School of Medicine, New York, New York 10016, USAc Address for correspondence and reprint requests: Kenneth R. Alper, M.D. Brain Research Laboratories, Department of Psychiatry, New York University School of Medicine, 550 First Avenue, New York, NY 10016. Voice: 212–263–6287. e-mail: Kra1@is9.nyu.eduSearch for more papers by this authorHOWARD S. LOTSOF, HOWARD S. LOTSOF NDA International, Staten Island, New York, USASearch for more papers by this authorGEERTE M. N. FRENKEN, GEERTE M. N. FRENKEN National Development and Research Institute (NDRI), New York, New York, USASearch for more papers by this authorDANIEL J. LUCIANO, DANIEL J. LUCIANO Comprehensive Epilepsy Center, Department of Neurology, New York University School of Medicine, New York, New York 10016, USASearch for more papers by this authorJAN BASTIAANS, JAN BASTIAANS Department of Psychiatry, State University of Leiden, The Netherlands Deceased.Search for more papers by this author KENNETH R. ALPER, Corresponding Author KENNETH R. ALPER Brain Research Laboratories, Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA Comprehensive Epilepsy Center, Department of Neurology, New York University School of Medicine, New York, New York 10016, USAc Address for correspondence and reprint requests: Kenneth R. Alper, M.D. Brain Research Laboratories, Department of Psychiatry, New York University School of Medicine, 550 First Avenue, New York, NY 10016. Voice: 212–263–6287. e-mail: Kra1@is9.nyu.eduSearch for more papers by this authorHOWARD S. LOTSOF, HOWARD S. LOTSOF NDA International, Staten Island, New York, USASearch for more papers by this authorGEERTE M. N. FRENKEN, GEERTE M. N. FRENKEN National Development and Research Institute (NDRI), New York, New York, USASearch for more papers by this authorDANIEL J. LUCIANO, DANIEL J. LUCIANO Comprehensive Epilepsy Center, Department of Neurology, New York University School of Medicine, New York, New York 10016, USASearch for more papers by this authorJAN BASTIAANS, JAN BASTIAANS Department of Psychiatry, State University of Leiden, The Netherlands Deceased.Search for more papers by this author First published: 25 January 2006 https://doi.org/10.1111/j.1749-6632.2000.tb06687.xCitations: 11 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume909, Issue1NEW MEDICATIONS FOR DRUG ABUSEJanuary 2000Pages 257-259 RelatedInformation